A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Taxane (docetaxel or paclitaxel)
Sponsor: Hoffmann-La Roche